Memorial Sloan Kettering Takes Major Step Toward Improving Clinical Trials

Memorial Sloan Kettering Cancer Center is utilizing an AI platform called Triomics to improve the efficiency of clinical trial patient matching amidst challenges posed by unstructured data. The existing manual processes slow down screening and increase the potential for errors, ultimately hindering patient enrollment in vital trials. By integrating Triomics with their electronic health record and research systems, the center aims to streamline data management, allowing research coordinators to focus more on patient care. This advancement highlights the significant role of AI in enhancing clinical research processes and improving patient outcomes in cancer treatment.

Opens on Healthcare IT News